Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Reagents and Kits
1.3 Market by Application
1.3.1 Global In-Vitro Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Cancer Diagnostics Market Perspective (2019-2030)
2.2 In-Vitro Cancer Diagnostics Growth Trends by Region
2.2.1 Global In-Vitro Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In-Vitro Cancer Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 In-Vitro Cancer Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 In-Vitro Cancer Diagnostics Market Dynamics
2.3.1 In-Vitro Cancer Diagnostics Industry Trends
2.3.2 In-Vitro Cancer Diagnostics Market Drivers
2.3.3 In-Vitro Cancer Diagnostics Market Challenges
2.3.4 In-Vitro Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue
3.1.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue (2019-2024)
3.1.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Cancer Diagnostics Revenue
3.4 Global In-Vitro Cancer Diagnostics Market Concentration Ratio
3.4.1 Global In-Vitro Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Cancer Diagnostics Revenue in 2023
3.5 In-Vitro Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players In-Vitro Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into In-Vitro Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Cancer Diagnostics Breakdown Data by Type
4.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2025-2030)
5 In-Vitro Cancer Diagnostics Breakdown Data by Application
5.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In-Vitro Cancer Diagnostics Market Size (2019-2030)
6.2 North America In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
6.4 North America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Cancer Diagnostics Market Size (2019-2030)
7.2 Europe In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
7.4 Europe In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Cancer Diagnostics Market Size (2019-2030)
9.2 Latin America In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
9.4 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MDx Health Quest Diagnostics
11.1.1 MDx Health Quest Diagnostics Company Detail
11.1.2 MDx Health Quest Diagnostics Business Overview
11.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Introduction
11.1.4 MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.1.5 MDx Health Quest Diagnostics Recent Development
11.2 R-Biopharm AG
11.2.1 R-Biopharm AG Company Detail
11.2.2 R-Biopharm AG Business Overview
11.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Introduction
11.2.4 R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.2.5 R-Biopharm AG Recent Development
11.3 Signature Diagnostics
11.3.1 Signature Diagnostics Company Detail
11.3.2 Signature Diagnostics Business Overview
11.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Introduction
11.3.4 Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.3.5 Signature Diagnostics Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Detail
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Introduction
11.4.4 Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.4.5 Siemens Healthcare Recent Development
11.5 Randox Laboratories
11.5.1 Randox Laboratories Company Detail
11.5.2 Randox Laboratories Business Overview
11.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Introduction
11.5.4 Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.5.5 Randox Laboratories Recent Development
11.6 Epigenomics AG
11.6.1 Epigenomics AG Company Detail
11.6.2 Epigenomics AG Business Overview
11.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Introduction
11.6.4 Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.6.5 Epigenomics AG Recent Development
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Detail
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Introduction
11.7.4 Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.7.5 Beckman Coulter Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Introduction
11.8.4 Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.8.5 Abbott Laboratories Recent Development
11.9 Burning Rock
11.9.1 Burning Rock Company Detail
11.9.2 Burning Rock Business Overview
11.9.3 Burning Rock In-Vitro Cancer Diagnostics Introduction
11.9.4 Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.9.5 Burning Rock Recent Development
11.10 Novogene
11.10.1 Novogene Company Detail
11.10.2 Novogene Business Overview
11.10.3 Novogene In-Vitro Cancer Diagnostics Introduction
11.10.4 Novogene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.10.5 Novogene Recent Development
11.11 Geneseeq
11.11.1 Geneseeq Company Detail
11.11.2 Geneseeq Business Overview
11.11.3 Geneseeq In-Vitro Cancer Diagnostics Introduction
11.11.4 Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.11.5 Geneseeq Recent Development
11.12 Amoy Diagnostics Co.,Ltd.
11.12.1 Amoy Diagnostics Co.,Ltd. Company Detail
11.12.2 Amoy Diagnostics Co.,Ltd. Business Overview
11.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Introduction
11.12.4 Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.12.5 Amoy Diagnostics Co.,Ltd. Recent Development
11.13 Daan Gene
11.13.1 Daan Gene Company Detail
11.13.2 Daan Gene Business Overview
11.13.3 Daan Gene In-Vitro Cancer Diagnostics Introduction
11.13.4 Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.13.5 Daan Gene Recent Development
11.14 Fosun Pharma
11.14.1 Fosun Pharma Company Detail
11.14.2 Fosun Pharma Business Overview
11.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Introduction
11.14.4 Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.14.5 Fosun Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details